nodes	percent_of_prediction	percent_of_DWPC	metapath
Amitriptyline—ABCB1—colon cancer	0.28	1	CbGaD
Amitriptyline—CYP2B6—Irinotecan—colon cancer	0.0396	0.107	CbGbCtD
Amitriptyline—ALB—Irinotecan—colon cancer	0.0388	0.105	CbGbCtD
Amitriptyline—ALB—Fluorouracil—colon cancer	0.0372	0.1	CbGbCtD
Amitriptyline—CYP2C9—Capecitabine—colon cancer	0.0338	0.0912	CbGbCtD
Amitriptyline—CYP3A5—Irinotecan—colon cancer	0.0312	0.084	CbGbCtD
Amitriptyline—CYP2C8—Fluorouracil—colon cancer	0.0287	0.0775	CbGbCtD
Amitriptyline—CYP3A5—Vincristine—colon cancer	0.0272	0.0735	CbGbCtD
Amitriptyline—CYP1A2—Fluorouracil—colon cancer	0.0223	0.06	CbGbCtD
Amitriptyline—ALB—Methotrexate—colon cancer	0.0205	0.0553	CbGbCtD
Amitriptyline—ABCB1—Irinotecan—colon cancer	0.0203	0.0547	CbGbCtD
Amitriptyline—CYP2C9—Fluorouracil—colon cancer	0.0201	0.0541	CbGbCtD
Amitriptyline—ABCB1—Vincristine—colon cancer	0.0177	0.0478	CbGbCtD
Amitriptyline—CYP3A4—Irinotecan—colon cancer	0.0121	0.0328	CbGbCtD
Amitriptyline—ABCB1—Methotrexate—colon cancer	0.0107	0.0289	CbGbCtD
Amitriptyline—CYP3A4—Vincristine—colon cancer	0.0106	0.0286	CbGbCtD
Amitriptyline—CHRM3—ureter—colon cancer	0.00986	0.0853	CbGeAlD
Amitriptyline—HTR7—myenteric nerve plexus—colon cancer	0.00808	0.0699	CbGeAlD
Amitriptyline—ORM1—bile—colon cancer	0.00775	0.067	CbGeAlD
Amitriptyline—CHRM3—muscle of abdomen—colon cancer	0.0071	0.0614	CbGeAlD
Amitriptyline—HTR7—vein—colon cancer	0.00521	0.0451	CbGeAlD
Amitriptyline—HTR2A—myenteric nerve plexus—colon cancer	0.00504	0.0436	CbGeAlD
Amitriptyline—HTR2A—vein—colon cancer	0.00325	0.0281	CbGeAlD
Amitriptyline—HRH4—bone marrow—colon cancer	0.00264	0.0229	CbGeAlD
Amitriptyline—NTRK2—bone marrow—colon cancer	0.00247	0.0214	CbGeAlD
Amitriptyline—ORM1—gall bladder—colon cancer	0.00215	0.0186	CbGeAlD
Amitriptyline—HTR1B—blood vessel—colon cancer	0.00214	0.0185	CbGeAlD
Amitriptyline—HTR1D—blood vessel—colon cancer	0.00208	0.018	CbGeAlD
Amitriptyline—Ileus paralytic—Capecitabine—colon cancer	0.00205	0.0141	CcSEcCtD
Amitriptyline—Bone marrow depression—Vincristine—colon cancer	0.00201	0.0138	CcSEcCtD
Amitriptyline—ALB—gall bladder—colon cancer	0.00189	0.0163	CbGeAlD
Amitriptyline—HTR7—endothelium—colon cancer	0.00179	0.0155	CbGeAlD
Amitriptyline—Cardiomyopathy—Capecitabine—colon cancer	0.00173	0.0119	CcSEcCtD
Amitriptyline—HTR7—blood vessel—colon cancer	0.00165	0.0143	CbGeAlD
Amitriptyline—Numbness—Vincristine—colon cancer	0.00164	0.0113	CcSEcCtD
Amitriptyline—Tingling sensation—Fluorouracil—colon cancer	0.00158	0.0108	CcSEcCtD
Amitriptyline—Sensory loss—Vincristine—colon cancer	0.00157	0.0108	CcSEcCtD
Amitriptyline—OPRD1—renal system—colon cancer	0.00155	0.0134	CbGeAlD
Amitriptyline—NTRK2—lymph node—colon cancer	0.00153	0.0133	CbGeAlD
Amitriptyline—Numbness—Fluorouracil—colon cancer	0.00153	0.0105	CcSEcCtD
Amitriptyline—CHRM5—epithelium—colon cancer	0.00151	0.0131	CbGeAlD
Amitriptyline—Sensory loss—Fluorouracil—colon cancer	0.00146	0.0101	CcSEcCtD
Amitriptyline—Dysarthria—Irinotecan—colon cancer	0.0014	0.00962	CcSEcCtD
Amitriptyline—ADRA1D—epithelium—colon cancer	0.00135	0.0117	CbGeAlD
Amitriptyline—Dysarthria—Fluorouracil—colon cancer	0.00134	0.00921	CcSEcCtD
Amitriptyline—Bone marrow depression—Capecitabine—colon cancer	0.00131	0.00902	CcSEcCtD
Amitriptyline—ADRA1B—renal system—colon cancer	0.00128	0.0111	CbGeAlD
Amitriptyline—Torsade de pointes—Capecitabine—colon cancer	0.00126	0.00868	CcSEcCtD
Amitriptyline—Coma—Vincristine—colon cancer	0.00124	0.00853	CcSEcCtD
Amitriptyline—HRH2—digestive system—colon cancer	0.0012	0.0104	CbGeAlD
Amitriptyline—Coma—Fluorouracil—colon cancer	0.00116	0.00796	CcSEcCtD
Amitriptyline—Ventricular fibrillation—Capecitabine—colon cancer	0.00116	0.00795	CcSEcCtD
Amitriptyline—KCND3—liver—colon cancer	0.00115	0.00995	CbGeAlD
Amitriptyline—HTR2A—endothelium—colon cancer	0.00112	0.00967	CbGeAlD
Amitriptyline—Tingling sensation—Capecitabine—colon cancer	0.0011	0.00757	CcSEcCtD
Amitriptyline—Hepatic failure—Vincristine—colon cancer	0.0011	0.00754	CcSEcCtD
Amitriptyline—Ageusia—Capecitabine—colon cancer	0.00109	0.00751	CcSEcCtD
Amitriptyline—HTR2A—blood vessel—colon cancer	0.00103	0.00892	CbGeAlD
Amitriptyline—Disorientation—Fluorouracil—colon cancer	0.00103	0.00707	CcSEcCtD
Amitriptyline—Cerebrovascular accident—Irinotecan—colon cancer	0.00098	0.00674	CcSEcCtD
Amitriptyline—Bone marrow depression—Methotrexate—colon cancer	0.000977	0.00671	CcSEcCtD
Amitriptyline—Osteoarthritis—Irinotecan—colon cancer	0.000961	0.0066	CcSEcCtD
Amitriptyline—Urinary retention—Vincristine—colon cancer	0.000938	0.00645	CcSEcCtD
Amitriptyline—Dysarthria—Capecitabine—colon cancer	0.000936	0.00644	CcSEcCtD
Amitriptyline—Ataxia—Vincristine—colon cancer	0.000928	0.00638	CcSEcCtD
Amitriptyline—Osteoarthritis—Fluorouracil—colon cancer	0.00092	0.00632	CcSEcCtD
Amitriptyline—SIGMAR1—smooth muscle tissue—colon cancer	0.000908	0.00785	CbGeAlD
Amitriptyline—Coordination abnormal—Capecitabine—colon cancer	0.000902	0.0062	CcSEcCtD
Amitriptyline—HRH2—liver—colon cancer	0.000897	0.00776	CbGeAlD
Amitriptyline—KCND3—lymph node—colon cancer	0.000882	0.00763	CbGeAlD
Amitriptyline—Irritability—Fluorouracil—colon cancer	0.000878	0.00604	CcSEcCtD
Amitriptyline—Orthostatic hypotension—Irinotecan—colon cancer	0.000877	0.00603	CcSEcCtD
Amitriptyline—Ataxia—Fluorouracil—colon cancer	0.000865	0.00595	CcSEcCtD
Amitriptyline—CHRM3—smooth muscle tissue—colon cancer	0.000815	0.00705	CbGeAlD
Amitriptyline—Pancytopenia—Vincristine—colon cancer	0.00081	0.00556	CcSEcCtD
Amitriptyline—Sweating increased—Irinotecan—colon cancer	0.000809	0.00556	CcSEcCtD
Amitriptyline—HTR7—epithelium—colon cancer	0.000805	0.00696	CbGeAlD
Amitriptyline—Eosinophilia—Fluorouracil—colon cancer	0.000787	0.00541	CcSEcCtD
Amitriptyline—Erectile dysfunction—Vincristine—colon cancer	0.000785	0.0054	CcSEcCtD
Amitriptyline—CHRM3—renal system—colon cancer	0.000784	0.00678	CbGeAlD
Amitriptyline—HTR1A—renal system—colon cancer	0.000781	0.00676	CbGeAlD
Amitriptyline—ORM1—bone marrow—colon cancer	0.000781	0.00675	CbGeAlD
Amitriptyline—ADRA1A—epithelium—colon cancer	0.000776	0.00671	CbGeAlD
Amitriptyline—HTR7—smooth muscle tissue—colon cancer	0.000775	0.00671	CbGeAlD
Amitriptyline—Mental disability—Capecitabine—colon cancer	0.000769	0.00528	CcSEcCtD
Amitriptyline—Pancytopenia—Fluorouracil—colon cancer	0.000755	0.00519	CcSEcCtD
Amitriptyline—Acute coronary syndrome—Vincristine—colon cancer	0.000749	0.00515	CcSEcCtD
Amitriptyline—HTR7—renal system—colon cancer	0.000746	0.00646	CbGeAlD
Amitriptyline—Myocardial infarction—Vincristine—colon cancer	0.000745	0.00512	CcSEcCtD
Amitriptyline—Neuropathy peripheral—Vincristine—colon cancer	0.000745	0.00512	CcSEcCtD
Amitriptyline—Sleep disorder—Capecitabine—colon cancer	0.000743	0.0051	CcSEcCtD
Amitriptyline—Stomatitis—Vincristine—colon cancer	0.000741	0.00509	CcSEcCtD
Amitriptyline—Acute coronary syndrome—Irinotecan—colon cancer	0.00073	0.00502	CcSEcCtD
Amitriptyline—Myocardial infarction—Irinotecan—colon cancer	0.000726	0.00499	CcSEcCtD
Amitriptyline—Jaundice—Irinotecan—colon cancer	0.000722	0.00496	CcSEcCtD
Amitriptyline—Stomatitis—Irinotecan—colon cancer	0.000722	0.00496	CcSEcCtD
Amitriptyline—SLC6A4—digestive system—colon cancer	0.000721	0.00624	CbGeAlD
Amitriptyline—ADRA1A—renal system—colon cancer	0.00072	0.00623	CbGeAlD
Amitriptyline—Vascular purpura—Capecitabine—colon cancer	0.000719	0.00494	CcSEcCtD
Amitriptyline—Hepatic failure—Capecitabine—colon cancer	0.000715	0.00492	CcSEcCtD
Amitriptyline—Acute coronary syndrome—Fluorouracil—colon cancer	0.000699	0.0048	CcSEcCtD
Amitriptyline—Dysarthria—Methotrexate—colon cancer	0.000697	0.00479	CcSEcCtD
Amitriptyline—Myocardial infarction—Fluorouracil—colon cancer	0.000695	0.00478	CcSEcCtD
Amitriptyline—Neuropathy peripheral—Fluorouracil—colon cancer	0.000695	0.00478	CcSEcCtD
Amitriptyline—Libido decreased—Capecitabine—colon cancer	0.000693	0.00477	CcSEcCtD
Amitriptyline—Stomatitis—Fluorouracil—colon cancer	0.000691	0.00475	CcSEcCtD
Amitriptyline—HRH2—lymph node—colon cancer	0.000688	0.00595	CbGeAlD
Amitriptyline—Hallucination—Vincristine—colon cancer	0.000679	0.00467	CcSEcCtD
Amitriptyline—Hypoaesthesia—Vincristine—colon cancer	0.000679	0.00467	CcSEcCtD
Amitriptyline—ABCB1—blood vessel—colon cancer	0.000676	0.00584	CbGeAlD
Amitriptyline—Purpura—Capecitabine—colon cancer	0.000667	0.00459	CcSEcCtD
Amitriptyline—Agranulocytosis—Fluorouracil—colon cancer	0.000662	0.00455	CcSEcCtD
Amitriptyline—Arthritis—Capecitabine—colon cancer	0.000662	0.00455	CcSEcCtD
Amitriptyline—SIGMAR1—bone marrow—colon cancer	0.000661	0.00571	CbGeAlD
Amitriptyline—Cerebrovascular accident—Capecitabine—colon cancer	0.000656	0.00451	CcSEcCtD
Amitriptyline—CHRM3—digestive system—colon cancer	0.000643	0.00556	CbGeAlD
Amitriptyline—Osteoarthritis—Capecitabine—colon cancer	0.000643	0.00442	CcSEcCtD
Amitriptyline—Disturbance in sexual arousal—Capecitabine—colon cancer	0.000638	0.00438	CcSEcCtD
Amitriptyline—CYP2C8—renal system—colon cancer	0.000636	0.0055	CbGeAlD
Amitriptyline—Hypoaesthesia—Fluorouracil—colon cancer	0.000633	0.00435	CcSEcCtD
Amitriptyline—SIGMAR1—vagina—colon cancer	0.000633	0.00547	CbGeAlD
Amitriptyline—ORM1—liver—colon cancer	0.000631	0.00546	CbGeAlD
Amitriptyline—HTR2A—embryo—colon cancer	0.000615	0.00532	CbGeAlD
Amitriptyline—Irritability—Capecitabine—colon cancer	0.000614	0.00422	CcSEcCtD
Amitriptyline—HTR7—digestive system—colon cancer	0.000612	0.0053	CbGeAlD
Amitriptyline—Urinary retention—Capecitabine—colon cancer	0.000611	0.0042	CcSEcCtD
Amitriptyline—Ataxia—Capecitabine—colon cancer	0.000605	0.00416	CcSEcCtD
Amitriptyline—Alopecia—Vincristine—colon cancer	0.000603	0.00414	CcSEcCtD
Amitriptyline—Coma—Methotrexate—colon cancer	0.000603	0.00414	CcSEcCtD
Amitriptyline—HRH1—epithelium—colon cancer	0.000601	0.0052	CbGeAlD
Amitriptyline—CYP2C19—digestive system—colon cancer	0.000598	0.00517	CbGeAlD
Amitriptyline—ADRA1A—lymphoid tissue—colon cancer	0.000598	0.00517	CbGeAlD
Amitriptyline—CYP1A2—renal system—colon cancer	0.000595	0.00515	CbGeAlD
Amitriptyline—Arrhythmia—Irinotecan—colon cancer	0.000594	0.00408	CcSEcCtD
Amitriptyline—Gynaecomastia—Methotrexate—colon cancer	0.00059	0.00405	CcSEcCtD
Amitriptyline—Alopecia—Irinotecan—colon cancer	0.000587	0.00404	CcSEcCtD
Amitriptyline—Orthostatic hypotension—Capecitabine—colon cancer	0.000587	0.00404	CcSEcCtD
Amitriptyline—HRH1—smooth muscle tissue—colon cancer	0.000579	0.00501	CbGeAlD
Amitriptyline—CYP3A5—renal system—colon cancer	0.000574	0.00497	CbGeAlD
Amitriptyline—CYP2B6—renal system—colon cancer	0.000571	0.00494	CbGeAlD
Amitriptyline—Arrhythmia—Fluorouracil—colon cancer	0.000569	0.00391	CcSEcCtD
Amitriptyline—Alopecia—Fluorouracil—colon cancer	0.000562	0.00387	CcSEcCtD
Amitriptyline—ALB—liver—colon cancer	0.000553	0.00478	CbGeAlD
Amitriptyline—Agitation—Vincristine—colon cancer	0.000546	0.00375	CcSEcCtD
Amitriptyline—Sweating increased—Capecitabine—colon cancer	0.000541	0.00372	CcSEcCtD
Amitriptyline—Ill-defined disorder—Irinotecan—colon cancer	0.000537	0.00369	CcSEcCtD
Amitriptyline—CYP2E1—renal system—colon cancer	0.000536	0.00463	CbGeAlD
Amitriptyline—SIGMAR1—liver—colon cancer	0.000534	0.00462	CbGeAlD
Amitriptyline—Hepatic failure—Methotrexate—colon cancer	0.000533	0.00366	CcSEcCtD
Amitriptyline—Leukopenia—Vincristine—colon cancer	0.000532	0.00365	CcSEcCtD
Amitriptyline—CYP2C19—vagina—colon cancer	0.000528	0.00457	CbGeAlD
Amitriptyline—Pancytopenia—Capecitabine—colon cancer	0.000528	0.00363	CcSEcCtD
Amitriptyline—Vision blurred—Fluorouracil—colon cancer	0.000522	0.00359	CcSEcCtD
Amitriptyline—Malaise—Irinotecan—colon cancer	0.000522	0.00359	CcSEcCtD
Amitriptyline—Syncope—Irinotecan—colon cancer	0.000519	0.00357	CcSEcCtD
Amitriptyline—Leukopenia—Irinotecan—colon cancer	0.000518	0.00356	CcSEcCtD
Amitriptyline—Convulsion—Vincristine—colon cancer	0.000515	0.00354	CcSEcCtD
Amitriptyline—Hypertension—Vincristine—colon cancer	0.000513	0.00353	CcSEcCtD
Amitriptyline—Loss of consciousness—Irinotecan—colon cancer	0.000509	0.00349	CcSEcCtD
Amitriptyline—Weight increased—Capecitabine—colon cancer	0.000506	0.00348	CcSEcCtD
Amitriptyline—HTR2A—epithelium—colon cancer	0.000502	0.00434	CbGeAlD
Amitriptyline—Hypertension—Irinotecan—colon cancer	0.0005	0.00343	CcSEcCtD
Amitriptyline—Leukopenia—Fluorouracil—colon cancer	0.000496	0.00341	CcSEcCtD
Amitriptyline—Acute coronary syndrome—Capecitabine—colon cancer	0.000488	0.00336	CcSEcCtD
Amitriptyline—Cerebrovascular accident—Methotrexate—colon cancer	0.000488	0.00336	CcSEcCtD
Amitriptyline—CYP1A2—digestive system—colon cancer	0.000488	0.00422	CbGeAlD
Amitriptyline—Discomfort—Irinotecan—colon cancer	0.000487	0.00334	CcSEcCtD
Amitriptyline—Myocardial infarction—Capecitabine—colon cancer	0.000486	0.00334	CcSEcCtD
Amitriptyline—Neuropathy peripheral—Capecitabine—colon cancer	0.000486	0.00334	CcSEcCtD
Amitriptyline—Oedema—Vincristine—colon cancer	0.000485	0.00333	CcSEcCtD
Amitriptyline—ORM1—lymph node—colon cancer	0.000484	0.00418	CbGeAlD
Amitriptyline—HTR2A—smooth muscle tissue—colon cancer	0.000484	0.00418	CbGeAlD
Amitriptyline—Jaundice—Capecitabine—colon cancer	0.000483	0.00332	CcSEcCtD
Amitriptyline—Stomatitis—Capecitabine—colon cancer	0.000483	0.00332	CcSEcCtD
Amitriptyline—Convulsion—Fluorouracil—colon cancer	0.00048	0.0033	CcSEcCtD
Amitriptyline—Osteoarthritis—Methotrexate—colon cancer	0.000479	0.00329	CcSEcCtD
Amitriptyline—Confusional state—Irinotecan—colon cancer	0.000476	0.00327	CcSEcCtD
Amitriptyline—Thrombocytopenia—Vincristine—colon cancer	0.000475	0.00326	CcSEcCtD
Amitriptyline—CYP2B6—lymphoid tissue—colon cancer	0.000474	0.0041	CbGeAlD
Amitriptyline—Oedema—Irinotecan—colon cancer	0.000472	0.00325	CcSEcCtD
Amitriptyline—CYP3A5—digestive system—colon cancer	0.000471	0.00407	CbGeAlD
Amitriptyline—Hyperhidrosis—Vincristine—colon cancer	0.000469	0.00322	CcSEcCtD
Amitriptyline—CYP2B6—digestive system—colon cancer	0.000468	0.00405	CbGeAlD
Amitriptyline—Discomfort—Fluorouracil—colon cancer	0.000466	0.0032	CcSEcCtD
Amitriptyline—HTR2A—renal system—colon cancer	0.000465	0.00403	CbGeAlD
Amitriptyline—Shock—Irinotecan—colon cancer	0.000465	0.00319	CcSEcCtD
Amitriptyline—CYP2C9—digestive system—colon cancer	0.000463	0.00401	CbGeAlD
Amitriptyline—Agranulocytosis—Capecitabine—colon cancer	0.000462	0.00318	CcSEcCtD
Amitriptyline—Thrombocytopenia—Irinotecan—colon cancer	0.000462	0.00318	CcSEcCtD
Amitriptyline—Anorexia—Vincristine—colon cancer	0.000462	0.00318	CcSEcCtD
Amitriptyline—CYP2C8—vagina—colon cancer	0.000461	0.00399	CbGeAlD
Amitriptyline—HRH1—digestive system—colon cancer	0.000457	0.00395	CbGeAlD
Amitriptyline—Irritability—Methotrexate—colon cancer	0.000457	0.00314	CcSEcCtD
Amitriptyline—Hyperhidrosis—Irinotecan—colon cancer	0.000456	0.00314	CcSEcCtD
Amitriptyline—HTR7—liver—colon cancer	0.000456	0.00394	CbGeAlD
Amitriptyline—Confusional state—Fluorouracil—colon cancer	0.000456	0.00313	CcSEcCtD
Amitriptyline—Hypotension—Vincristine—colon cancer	0.000453	0.00311	CcSEcCtD
Amitriptyline—Oedema—Fluorouracil—colon cancer	0.000452	0.00311	CcSEcCtD
Amitriptyline—Anorexia—Irinotecan—colon cancer	0.00045	0.00309	CcSEcCtD
Amitriptyline—Ataxia—Methotrexate—colon cancer	0.00045	0.00309	CcSEcCtD
Amitriptyline—CYP2C19—liver—colon cancer	0.000445	0.00385	CbGeAlD
Amitriptyline—Hepatitis—Capecitabine—colon cancer	0.000445	0.00306	CcSEcCtD
Amitriptyline—CYP2E1—lymphoid tissue—colon cancer	0.000445	0.00385	CbGeAlD
Amitriptyline—Thrombocytopenia—Fluorouracil—colon cancer	0.000443	0.00304	CcSEcCtD
Amitriptyline—Hypoaesthesia—Capecitabine—colon cancer	0.000443	0.00304	CcSEcCtD
Amitriptyline—Tachycardia—Fluorouracil—colon cancer	0.000441	0.00303	CcSEcCtD
Amitriptyline—Hypotension—Irinotecan—colon cancer	0.000441	0.00303	CcSEcCtD
Amitriptyline—ADRA1A—liver—colon cancer	0.00044	0.00381	CbGeAlD
Amitriptyline—CYP2E1—digestive system—colon cancer	0.000439	0.0038	CbGeAlD
Amitriptyline—Insomnia—Vincristine—colon cancer	0.000439	0.00301	CcSEcCtD
Amitriptyline—Paraesthesia—Vincristine—colon cancer	0.000435	0.00299	CcSEcCtD
Amitriptyline—Anorexia—Fluorouracil—colon cancer	0.000431	0.00296	CcSEcCtD
Amitriptyline—CYP3A4—renal system—colon cancer	0.000431	0.00373	CbGeAlD
Amitriptyline—Insomnia—Irinotecan—colon cancer	0.000427	0.00294	CcSEcCtD
Amitriptyline—ALB—lymph node—colon cancer	0.000424	0.00367	CbGeAlD
Amitriptyline—CYP2D6—renal system—colon cancer	0.000424	0.00367	CbGeAlD
Amitriptyline—Paraesthesia—Irinotecan—colon cancer	0.000424	0.00291	CcSEcCtD
Amitriptyline—Hypotension—Fluorouracil—colon cancer	0.000423	0.0029	CcSEcCtD
Amitriptyline—Decreased appetite—Vincristine—colon cancer	0.000421	0.0029	CcSEcCtD
Amitriptyline—Somnolence—Irinotecan—colon cancer	0.00042	0.00289	CcSEcCtD
Amitriptyline—Fatigue—Vincristine—colon cancer	0.000418	0.00287	CcSEcCtD
Amitriptyline—CYP3A5—vagina—colon cancer	0.000416	0.0036	CbGeAlD
Amitriptyline—Dyspepsia—Irinotecan—colon cancer	0.000416	0.00286	CcSEcCtD
Amitriptyline—Tinnitus—Capecitabine—colon cancer	0.000415	0.00285	CcSEcCtD
Amitriptyline—Constipation—Vincristine—colon cancer	0.000415	0.00285	CcSEcCtD
Amitriptyline—CYP2B6—vagina—colon cancer	0.000413	0.00357	CbGeAlD
Amitriptyline—Decreased appetite—Irinotecan—colon cancer	0.00041	0.00282	CcSEcCtD
Amitriptyline—Eosinophilia—Methotrexate—colon cancer	0.00041	0.00282	CcSEcCtD
Amitriptyline—SIGMAR1—lymph node—colon cancer	0.000409	0.00354	CbGeAlD
Amitriptyline—Insomnia—Fluorouracil—colon cancer	0.000409	0.00281	CcSEcCtD
Amitriptyline—Fatigue—Irinotecan—colon cancer	0.000407	0.0028	CcSEcCtD
Amitriptyline—Paraesthesia—Fluorouracil—colon cancer	0.000406	0.00279	CcSEcCtD
Amitriptyline—Constipation—Irinotecan—colon cancer	0.000404	0.00278	CcSEcCtD
Amitriptyline—HRH1—vagina—colon cancer	0.000404	0.00349	CbGeAlD
Amitriptyline—ABCB1—embryo—colon cancer	0.000403	0.00349	CbGeAlD
Amitriptyline—Somnolence—Fluorouracil—colon cancer	0.000402	0.00276	CcSEcCtD
Amitriptyline—Dyspepsia—Fluorouracil—colon cancer	0.000398	0.00274	CcSEcCtD
Amitriptyline—Arrhythmia—Capecitabine—colon cancer	0.000397	0.00273	CcSEcCtD
Amitriptyline—ADRA2A—vagina—colon cancer	0.000396	0.00343	CbGeAlD
Amitriptyline—Decreased appetite—Fluorouracil—colon cancer	0.000393	0.0027	CcSEcCtD
Amitriptyline—Alopecia—Capecitabine—colon cancer	0.000393	0.0027	CcSEcCtD
Amitriptyline—Pancytopenia—Methotrexate—colon cancer	0.000393	0.0027	CcSEcCtD
Amitriptyline—Feeling abnormal—Irinotecan—colon cancer	0.000389	0.00267	CcSEcCtD
Amitriptyline—CYP2C8—liver—colon cancer	0.000389	0.00336	CbGeAlD
Amitriptyline—Body temperature increased—Vincristine—colon cancer	0.000383	0.00263	CcSEcCtD
Amitriptyline—HTR2A—digestive system—colon cancer	0.000382	0.0033	CbGeAlD
Amitriptyline—Erectile dysfunction—Methotrexate—colon cancer	0.000381	0.00262	CcSEcCtD
Amitriptyline—Dysgeusia—Capecitabine—colon cancer	0.000379	0.00261	CcSEcCtD
Amitriptyline—Body temperature increased—Irinotecan—colon cancer	0.000373	0.00257	CcSEcCtD
Amitriptyline—Feeling abnormal—Fluorouracil—colon cancer	0.000373	0.00256	CcSEcCtD
Amitriptyline—Drowsiness—Methotrexate—colon cancer	0.000369	0.00254	CcSEcCtD
Amitriptyline—Vision blurred—Capecitabine—colon cancer	0.000365	0.00251	CcSEcCtD
Amitriptyline—CYP1A2—liver—colon cancer	0.000364	0.00315	CbGeAlD
Amitriptyline—SLC6A2—lymph node—colon cancer	0.000363	0.00314	CbGeAlD
Amitriptyline—Tremor—Capecitabine—colon cancer	0.000363	0.00249	CcSEcCtD
Amitriptyline—Stomatitis—Methotrexate—colon cancer	0.00036	0.00247	CcSEcCtD
Amitriptyline—Ill-defined disorder—Capecitabine—colon cancer	0.000359	0.00247	CcSEcCtD
Amitriptyline—Urticaria—Fluorouracil—colon cancer	0.000359	0.00247	CcSEcCtD
Amitriptyline—Body temperature increased—Fluorouracil—colon cancer	0.000358	0.00246	CcSEcCtD
Amitriptyline—CYP3A4—digestive system—colon cancer	0.000353	0.00306	CbGeAlD
Amitriptyline—CYP3A5—liver—colon cancer	0.000351	0.00303	CbGeAlD
Amitriptyline—Malaise—Capecitabine—colon cancer	0.000349	0.0024	CcSEcCtD
Amitriptyline—CYP2B6—liver—colon cancer	0.000349	0.00302	CbGeAlD
Amitriptyline—Asthenia—Vincristine—colon cancer	0.000348	0.00239	CcSEcCtD
Amitriptyline—CYP2D6—digestive system—colon cancer	0.000348	0.00301	CbGeAlD
Amitriptyline—Syncope—Capecitabine—colon cancer	0.000347	0.00239	CcSEcCtD
Amitriptyline—Leukopenia—Capecitabine—colon cancer	0.000347	0.00238	CcSEcCtD
Amitriptyline—CYP2C9—liver—colon cancer	0.000345	0.00299	CbGeAlD
Amitriptyline—Agranulocytosis—Methotrexate—colon cancer	0.000344	0.00237	CcSEcCtD
Amitriptyline—Palpitations—Capecitabine—colon cancer	0.000342	0.00235	CcSEcCtD
Amitriptyline—Loss of consciousness—Capecitabine—colon cancer	0.00034	0.00234	CcSEcCtD
Amitriptyline—Asthenia—Irinotecan—colon cancer	0.000339	0.00233	CcSEcCtD
Amitriptyline—HTR2A—vagina—colon cancer	0.000337	0.00292	CbGeAlD
Amitriptyline—Hypertension—Capecitabine—colon cancer	0.000334	0.0023	CcSEcCtD
Amitriptyline—Diarrhoea—Vincristine—colon cancer	0.000332	0.00228	CcSEcCtD
Amitriptyline—Hepatitis—Methotrexate—colon cancer	0.000331	0.00228	CcSEcCtD
Amitriptyline—ABCB1—epithelium—colon cancer	0.000329	0.00284	CbGeAlD
Amitriptyline—Anxiety—Capecitabine—colon cancer	0.000329	0.00226	CcSEcCtD
Amitriptyline—CYP2E1—liver—colon cancer	0.000327	0.00283	CbGeAlD
Amitriptyline—Discomfort—Capecitabine—colon cancer	0.000326	0.00224	CcSEcCtD
Amitriptyline—Diarrhoea—Irinotecan—colon cancer	0.000323	0.00222	CcSEcCtD
Amitriptyline—Dry mouth—Capecitabine—colon cancer	0.000322	0.00222	CcSEcCtD
Amitriptyline—Dizziness—Vincristine—colon cancer	0.000321	0.0022	CcSEcCtD
Amitriptyline—Pruritus—Fluorouracil—colon cancer	0.00032	0.0022	CcSEcCtD
Amitriptyline—Confusional state—Capecitabine—colon cancer	0.000319	0.00219	CcSEcCtD
Amitriptyline—Oedema—Capecitabine—colon cancer	0.000316	0.00217	CcSEcCtD
Amitriptyline—Dizziness—Irinotecan—colon cancer	0.000312	0.00215	CcSEcCtD
Amitriptyline—Shock—Capecitabine—colon cancer	0.000311	0.00214	CcSEcCtD
Amitriptyline—Diarrhoea—Fluorouracil—colon cancer	0.000309	0.00213	CcSEcCtD
Amitriptyline—Thrombocytopenia—Capecitabine—colon cancer	0.000309	0.00213	CcSEcCtD
Amitriptyline—Tinnitus—Methotrexate—colon cancer	0.000309	0.00212	CcSEcCtD
Amitriptyline—Tachycardia—Capecitabine—colon cancer	0.000308	0.00212	CcSEcCtD
Amitriptyline—Vomiting—Vincristine—colon cancer	0.000308	0.00212	CcSEcCtD
Amitriptyline—Rash—Vincristine—colon cancer	0.000306	0.0021	CcSEcCtD
Amitriptyline—Hyperhidrosis—Capecitabine—colon cancer	0.000306	0.0021	CcSEcCtD
Amitriptyline—Dermatitis—Vincristine—colon cancer	0.000305	0.0021	CcSEcCtD
Amitriptyline—ABCB1—renal system—colon cancer	0.000305	0.00264	CbGeAlD
Amitriptyline—Headache—Vincristine—colon cancer	0.000304	0.00209	CcSEcCtD
Amitriptyline—Anorexia—Capecitabine—colon cancer	0.000301	0.00207	CcSEcCtD
Amitriptyline—Vomiting—Irinotecan—colon cancer	0.0003	0.00206	CcSEcCtD
Amitriptyline—Dizziness—Fluorouracil—colon cancer	0.000299	0.00206	CcSEcCtD
Amitriptyline—Rash—Irinotecan—colon cancer	0.000298	0.00205	CcSEcCtD
Amitriptyline—Dermatitis—Irinotecan—colon cancer	0.000297	0.00204	CcSEcCtD
Amitriptyline—Headache—Irinotecan—colon cancer	0.000296	0.00203	CcSEcCtD
Amitriptyline—Hypotension—Capecitabine—colon cancer	0.000295	0.00203	CcSEcCtD
Amitriptyline—Alopecia—Methotrexate—colon cancer	0.000293	0.00201	CcSEcCtD
Amitriptyline—Nausea—Vincristine—colon cancer	0.000288	0.00198	CcSEcCtD
Amitriptyline—Vomiting—Fluorouracil—colon cancer	0.000288	0.00198	CcSEcCtD
Amitriptyline—Insomnia—Capecitabine—colon cancer	0.000286	0.00196	CcSEcCtD
Amitriptyline—Rash—Fluorouracil—colon cancer	0.000285	0.00196	CcSEcCtD
Amitriptyline—Dermatitis—Fluorouracil—colon cancer	0.000285	0.00196	CcSEcCtD
Amitriptyline—HTR2A—liver—colon cancer	0.000284	0.00246	CbGeAlD
Amitriptyline—Paraesthesia—Capecitabine—colon cancer	0.000284	0.00195	CcSEcCtD
Amitriptyline—Headache—Fluorouracil—colon cancer	0.000283	0.00195	CcSEcCtD
Amitriptyline—Dysgeusia—Methotrexate—colon cancer	0.000282	0.00194	CcSEcCtD
Amitriptyline—Nausea—Irinotecan—colon cancer	0.00028	0.00193	CcSEcCtD
Amitriptyline—Dyspepsia—Capecitabine—colon cancer	0.000278	0.00191	CcSEcCtD
Amitriptyline—Decreased appetite—Capecitabine—colon cancer	0.000275	0.00189	CcSEcCtD
Amitriptyline—Fatigue—Capecitabine—colon cancer	0.000272	0.00187	CcSEcCtD
Amitriptyline—Vision blurred—Methotrexate—colon cancer	0.000272	0.00187	CcSEcCtD
Amitriptyline—Constipation—Capecitabine—colon cancer	0.00027	0.00186	CcSEcCtD
Amitriptyline—Nausea—Fluorouracil—colon cancer	0.000269	0.00185	CcSEcCtD
Amitriptyline—Ill-defined disorder—Methotrexate—colon cancer	0.000267	0.00184	CcSEcCtD
Amitriptyline—CYP3A4—liver—colon cancer	0.000263	0.00228	CbGeAlD
Amitriptyline—HRH1—lymph node—colon cancer	0.000261	0.00226	CbGeAlD
Amitriptyline—Feeling abnormal—Capecitabine—colon cancer	0.00026	0.00179	CcSEcCtD
Amitriptyline—Malaise—Methotrexate—colon cancer	0.00026	0.00179	CcSEcCtD
Amitriptyline—CYP2D6—liver—colon cancer	0.000259	0.00224	CbGeAlD
Amitriptyline—Leukopenia—Methotrexate—colon cancer	0.000258	0.00177	CcSEcCtD
Amitriptyline—ADRA2A—lymph node—colon cancer	0.000256	0.00222	CbGeAlD
Amitriptyline—ABCB1—lymphoid tissue—colon cancer	0.000253	0.00219	CbGeAlD
Amitriptyline—Urticaria—Capecitabine—colon cancer	0.000251	0.00173	CcSEcCtD
Amitriptyline—ABCB1—digestive system—colon cancer	0.00025	0.00216	CbGeAlD
Amitriptyline—Body temperature increased—Capecitabine—colon cancer	0.00025	0.00172	CcSEcCtD
Amitriptyline—Convulsion—Methotrexate—colon cancer	0.00025	0.00172	CcSEcCtD
Amitriptyline—Discomfort—Methotrexate—colon cancer	0.000242	0.00167	CcSEcCtD
Amitriptyline—Confusional state—Methotrexate—colon cancer	0.000237	0.00163	CcSEcCtD
Amitriptyline—ABCB1—bone marrow—colon cancer	0.000231	0.00199	CbGeAlD
Amitriptyline—Thrombocytopenia—Methotrexate—colon cancer	0.00023	0.00158	CcSEcCtD
Amitriptyline—Hyperhidrosis—Methotrexate—colon cancer	0.000227	0.00156	CcSEcCtD
Amitriptyline—Asthenia—Capecitabine—colon cancer	0.000227	0.00156	CcSEcCtD
Amitriptyline—Anorexia—Methotrexate—colon cancer	0.000224	0.00154	CcSEcCtD
Amitriptyline—Pruritus—Capecitabine—colon cancer	0.000224	0.00154	CcSEcCtD
Amitriptyline—ABCB1—vagina—colon cancer	0.000221	0.00191	CbGeAlD
Amitriptyline—Hypotension—Methotrexate—colon cancer	0.00022	0.00151	CcSEcCtD
Amitriptyline—Diarrhoea—Capecitabine—colon cancer	0.000216	0.00149	CcSEcCtD
Amitriptyline—Insomnia—Methotrexate—colon cancer	0.000213	0.00146	CcSEcCtD
Amitriptyline—Paraesthesia—Methotrexate—colon cancer	0.000211	0.00145	CcSEcCtD
Amitriptyline—Somnolence—Methotrexate—colon cancer	0.000209	0.00144	CcSEcCtD
Amitriptyline—Dizziness—Capecitabine—colon cancer	0.000209	0.00144	CcSEcCtD
Amitriptyline—Dyspepsia—Methotrexate—colon cancer	0.000207	0.00142	CcSEcCtD
Amitriptyline—Decreased appetite—Methotrexate—colon cancer	0.000205	0.00141	CcSEcCtD
Amitriptyline—Fatigue—Methotrexate—colon cancer	0.000203	0.00139	CcSEcCtD
Amitriptyline—Epinastine—ABCB1—colon cancer	0.000202	0.235	CrCbGaD
Amitriptyline—Vomiting—Capecitabine—colon cancer	0.000201	0.00138	CcSEcCtD
Amitriptyline—Rash—Capecitabine—colon cancer	0.000199	0.00137	CcSEcCtD
Amitriptyline—Dermatitis—Capecitabine—colon cancer	0.000199	0.00137	CcSEcCtD
Amitriptyline—Headache—Capecitabine—colon cancer	0.000198	0.00136	CcSEcCtD
Amitriptyline—Feeling abnormal—Methotrexate—colon cancer	0.000194	0.00133	CcSEcCtD
Amitriptyline—Nausea—Capecitabine—colon cancer	0.000188	0.00129	CcSEcCtD
Amitriptyline—Urticaria—Methotrexate—colon cancer	0.000187	0.00128	CcSEcCtD
Amitriptyline—ABCB1—liver—colon cancer	0.000186	0.00161	CbGeAlD
Amitriptyline—Body temperature increased—Methotrexate—colon cancer	0.000186	0.00128	CcSEcCtD
Amitriptyline—Asthenia—Methotrexate—colon cancer	0.000169	0.00116	CcSEcCtD
Amitriptyline—Pruritus—Methotrexate—colon cancer	0.000166	0.00114	CcSEcCtD
Amitriptyline—Diarrhoea—Methotrexate—colon cancer	0.000161	0.00111	CcSEcCtD
Amitriptyline—Dizziness—Methotrexate—colon cancer	0.000156	0.00107	CcSEcCtD
Amitriptyline—Vomiting—Methotrexate—colon cancer	0.00015	0.00103	CcSEcCtD
Amitriptyline—Rash—Methotrexate—colon cancer	0.000148	0.00102	CcSEcCtD
Amitriptyline—Dermatitis—Methotrexate—colon cancer	0.000148	0.00102	CcSEcCtD
Amitriptyline—Headache—Methotrexate—colon cancer	0.000147	0.00101	CcSEcCtD
Amitriptyline—ABCB1—lymph node—colon cancer	0.000143	0.00124	CbGeAlD
Amitriptyline—Nausea—Methotrexate—colon cancer	0.00014	0.00096	CcSEcCtD
Amitriptyline—Clomipramine—ABCB1—colon cancer	0.000107	0.124	CrCbGaD
Amitriptyline—Chlorprothixene—ABCB1—colon cancer	0.000107	0.124	CrCbGaD
Amitriptyline—Trimipramine—ABCB1—colon cancer	9.86e-05	0.114	CrCbGaD
Amitriptyline—Promethazine—ABCB1—colon cancer	9.49e-05	0.11	CrCbGaD
Amitriptyline—Doxepin—ABCB1—colon cancer	9.39e-05	0.109	CrCbGaD
Amitriptyline—Desipramine—ABCB1—colon cancer	8.62e-05	0.0999	CrCbGaD
Amitriptyline—Imipramine—ABCB1—colon cancer	7.31e-05	0.0847	CrCbGaD
Amitriptyline—CHRM2—Signaling Pathways—CASP3—colon cancer	6.01e-06	6.87e-05	CbGpPWpGaD
Amitriptyline—OPRD1—Signaling Pathways—AKT1—colon cancer	5.99e-06	6.85e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—CTNNB1—colon cancer	5.99e-06	6.85e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—CASP3—colon cancer	5.99e-06	6.85e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—PIK3CA—colon cancer	5.98e-06	6.84e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—VEGFA—colon cancer	5.98e-06	6.83e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Metabolism—EP300—colon cancer	5.96e-06	6.82e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—TP53—colon cancer	5.96e-06	6.81e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—CCND1—colon cancer	5.96e-06	6.81e-05	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—HRAS—colon cancer	5.95e-06	6.8e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—CCND1—colon cancer	5.94e-06	6.79e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—PPARG—colon cancer	5.94e-06	6.79e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—NRAS—colon cancer	5.94e-06	6.79e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—CCND1—colon cancer	5.92e-06	6.77e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—KRAS—colon cancer	5.92e-06	6.77e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—NRAS—colon cancer	5.91e-06	6.75e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—CCND1—colon cancer	5.9e-06	6.75e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—CTNNB1—colon cancer	5.9e-06	6.74e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—PPARG—colon cancer	5.89e-06	6.73e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—CTNNB1—colon cancer	5.88e-06	6.73e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—SRC—colon cancer	5.88e-06	6.72e-05	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—HRAS—colon cancer	5.87e-06	6.71e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—CTNNB1—colon cancer	5.87e-06	6.71e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—KRAS—colon cancer	5.86e-06	6.7e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—KRAS—colon cancer	5.86e-06	6.7e-05	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—HRAS—colon cancer	5.86e-06	6.7e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—CDKN1A—colon cancer	5.86e-06	6.69e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—CCND1—colon cancer	5.85e-06	6.68e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—CTNNB1—colon cancer	5.85e-06	6.68e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—CCND1—colon cancer	5.83e-06	6.67e-05	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—HRAS—colon cancer	5.82e-06	6.66e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—CTNNB1—colon cancer	5.79e-06	6.62e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—TP53—colon cancer	5.79e-06	6.61e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling by GPCR—HRAS—colon cancer	5.78e-06	6.6e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—CTNNB1—colon cancer	5.77e-06	6.6e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—CDKN1A—colon cancer	5.76e-06	6.59e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—CDKN1A—colon cancer	5.75e-06	6.57e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—CDKN1A—colon cancer	5.73e-06	6.55e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—PIK3CA—colon cancer	5.73e-06	6.55e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—VEGFA—colon cancer	5.72e-06	6.54e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—CDKN1A—colon cancer	5.71e-06	6.53e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—HRAS—colon cancer	5.7e-06	6.52e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling by GPCR—AKT1—colon cancer	5.7e-06	6.51e-05	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—PTGS2—colon cancer	5.69e-06	6.51e-05	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—PTGS2—colon cancer	5.66e-06	6.47e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—CDKN1A—colon cancer	5.66e-06	6.47e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—NRAS—colon cancer	5.65e-06	6.46e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—CDKN1A—colon cancer	5.64e-06	6.45e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—GPCR downstream signaling—AKT1—colon cancer	5.62e-06	6.42e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling by GPCR—AKT1—colon cancer	5.61e-06	6.41e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling by GPCR—AKT1—colon cancer	5.6e-06	6.4e-05	CbGpPWpGaD
Amitriptyline—CYP2B6—Metabolism—EP300—colon cancer	5.59e-06	6.39e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—ABCB1—colon cancer	5.58e-06	6.38e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling by GPCR—AKT1—colon cancer	5.58e-06	6.38e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—EP300—colon cancer	5.57e-06	6.37e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—CASP3—colon cancer	5.57e-06	6.36e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling by GPCR—AKT1—colon cancer	5.56e-06	6.36e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—TP53—colon cancer	5.54e-06	6.33e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—HRAS—colon cancer	5.53e-06	6.33e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—MYC—colon cancer	5.53e-06	6.32e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—TGFB1—colon cancer	5.52e-06	6.31e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling by GPCR—AKT1—colon cancer	5.51e-06	6.29e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—MYC—colon cancer	5.5e-06	6.29e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling by GPCR—AKT1—colon cancer	5.49e-06	6.28e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—TGFB1—colon cancer	5.49e-06	6.27e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—TYMS—colon cancer	5.48e-06	6.27e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—EP300—colon cancer	5.48e-06	6.27e-05	CbGpPWpGaD
Amitriptyline—CYP2E1—Metabolism—EP300—colon cancer	5.48e-06	6.26e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—EP300—colon cancer	5.47e-06	6.25e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	5.47e-06	6.25e-05	CbGpPWpGaD
Amitriptyline—CYP3A5—Metabolism—EP300—colon cancer	5.47e-06	6.25e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—EP300—colon cancer	5.45e-06	6.23e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—PIK3CA—colon cancer	5.44e-06	6.22e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—EP300—colon cancer	5.44e-06	6.21e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—CCND1—colon cancer	5.42e-06	6.19e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—SRC—colon cancer	5.42e-06	6.19e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—EGFR—colon cancer	5.41e-06	6.18e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—PIK3CA—colon cancer	5.39e-06	6.16e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—PIK3CA—colon cancer	5.39e-06	6.16e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—EP300—colon cancer	5.38e-06	6.15e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—EGFR—colon cancer	5.38e-06	6.15e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—EP300—colon cancer	5.37e-06	6.14e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—CTNNB1—colon cancer	5.37e-06	6.13e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—SRC—colon cancer	5.33e-06	6.09e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—SRC—colon cancer	5.32e-06	6.08e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—SRC—colon cancer	5.3e-06	6.06e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—HRAS—colon cancer	5.3e-06	6.06e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—SRC—colon cancer	5.29e-06	6.04e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—VEGFA—colon cancer	5.28e-06	6.03e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—MYC—colon cancer	5.27e-06	6.02e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—TP53—colon cancer	5.26e-06	6.01e-05	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—AKT1—colon cancer	5.26e-06	6.01e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—TGFB1—colon cancer	5.25e-06	6e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—CDKN1A—colon cancer	5.24e-06	5.99e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—SRC—colon cancer	5.23e-06	5.98e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—SRC—colon cancer	5.22e-06	5.97e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—NRAS—colon cancer	5.21e-06	5.96e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—TP53—colon cancer	5.21e-06	5.96e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—TP53—colon cancer	5.21e-06	5.96e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—VEGFA—colon cancer	5.19e-06	5.93e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—VEGFA—colon cancer	5.18e-06	5.92e-05	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—AKT1—colon cancer	5.18e-06	5.92e-05	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—AKT1—colon cancer	5.17e-06	5.91e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—VEGFA—colon cancer	5.16e-06	5.9e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—EGFR—colon cancer	5.15e-06	5.89e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—VEGFA—colon cancer	5.15e-06	5.88e-05	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—AKT1—colon cancer	5.14e-06	5.88e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—NRAS—colon cancer	5.13e-06	5.86e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—NRAS—colon cancer	5.12e-06	5.85e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—KRAS—colon cancer	5.11e-06	5.84e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling by GPCR—AKT1—colon cancer	5.1e-06	5.83e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—NRAS—colon cancer	5.1e-06	5.83e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—VEGFA—colon cancer	5.1e-06	5.83e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—NRAS—colon cancer	5.08e-06	5.81e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—VEGFA—colon cancer	5.08e-06	5.81e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—KRAS—colon cancer	5.08e-06	5.81e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—PTGS2—colon cancer	5.08e-06	5.81e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—NRAS—colon cancer	5.04e-06	5.76e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—AKT1—colon cancer	5.03e-06	5.75e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—PPARG—colon cancer	5.03e-06	5.75e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—HRAS—colon cancer	5.03e-06	5.75e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—NRAS—colon cancer	5.02e-06	5.74e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—EP300—colon cancer	4.99e-06	5.7e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—HRAS—colon cancer	4.98e-06	5.7e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—HRAS—colon cancer	4.98e-06	5.7e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—PTGS2—colon cancer	4.96e-06	5.67e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—AKT1—colon cancer	4.89e-06	5.59e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—KRAS—colon cancer	4.87e-06	5.56e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—MYC—colon cancer	4.85e-06	5.55e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—SRC—colon cancer	4.85e-06	5.54e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—TGFB1—colon cancer	4.84e-06	5.54e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Metabolism—PIK3CA—colon cancer	4.81e-06	5.5e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—MYC—colon cancer	4.78e-06	5.46e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—MYC—colon cancer	4.77e-06	5.45e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—TGFB1—colon cancer	4.77e-06	5.45e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—TGFB1—colon cancer	4.76e-06	5.44e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—MYC—colon cancer	4.75e-06	5.43e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—EGFR—colon cancer	4.75e-06	5.43e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—TGFB1—colon cancer	4.74e-06	5.42e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—MYC—colon cancer	4.74e-06	5.41e-05	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—EP300—colon cancer	4.73e-06	5.41e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—TGFB1—colon cancer	4.72e-06	5.4e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—VEGFA—colon cancer	4.72e-06	5.4e-05	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—EP300—colon cancer	4.71e-06	5.38e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—PIK3CA—colon cancer	4.69e-06	5.37e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—MYC—colon cancer	4.69e-06	5.36e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—AKT1—colon cancer	4.68e-06	5.35e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—TGFB1—colon cancer	4.68e-06	5.35e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—MYC—colon cancer	4.68e-06	5.35e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—PTGS2—colon cancer	4.67e-06	5.34e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—EGFR—colon cancer	4.67e-06	5.34e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—PIK3CA—colon cancer	4.67e-06	5.34e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—TGFB1—colon cancer	4.67e-06	5.33e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—NRAS—colon cancer	4.67e-06	5.33e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—EGFR—colon cancer	4.66e-06	5.33e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—EGFR—colon cancer	4.65e-06	5.31e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—PTGS2—colon cancer	4.63e-06	5.3e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—EGFR—colon cancer	4.63e-06	5.3e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—EGFR—colon cancer	4.59e-06	5.24e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—EGFR—colon cancer	4.57e-06	5.23e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—TP53—colon cancer	4.54e-06	5.19e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—TP53—colon cancer	4.52e-06	5.16e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—KRAS—colon cancer	4.49e-06	5.13e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—PIK3CA—colon cancer	4.47e-06	5.11e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—AKT1—colon cancer	4.44e-06	5.08e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—KRAS—colon cancer	4.41e-06	5.05e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Metabolism—PIK3CA—colon cancer	4.41e-06	5.04e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—KRAS—colon cancer	4.4e-06	5.03e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—AKT1—colon cancer	4.4e-06	5.03e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—AKT1—colon cancer	4.4e-06	5.03e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—KRAS—colon cancer	4.39e-06	5.02e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—KRAS—colon cancer	4.38e-06	5e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—MYC—colon cancer	4.35e-06	4.97e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—HRAS—colon cancer	4.34e-06	4.96e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—TGFB1—colon cancer	4.34e-06	4.96e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—KRAS—colon cancer	4.33e-06	4.95e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—TP53—colon cancer	4.32e-06	4.94e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—KRAS—colon cancer	4.32e-06	4.94e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—HRAS—colon cancer	4.32e-06	4.94e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—EGFR—colon cancer	4.25e-06	4.86e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—EP300—colon cancer	4.23e-06	4.83e-05	CbGpPWpGaD
Amitriptyline—CYP2B6—Metabolism—PIK3CA—colon cancer	4.14e-06	4.73e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—HRAS—colon cancer	4.14e-06	4.73e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—EP300—colon cancer	4.12e-06	4.71e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—PIK3CA—colon cancer	4.12e-06	4.71e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—PIK3CA—colon cancer	4.06e-06	4.64e-05	CbGpPWpGaD
Amitriptyline—CYP2E1—Metabolism—PIK3CA—colon cancer	4.05e-06	4.63e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—PIK3CA—colon cancer	4.05e-06	4.63e-05	CbGpPWpGaD
Amitriptyline—CYP3A5—Metabolism—PIK3CA—colon cancer	4.04e-06	4.62e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—PIK3CA—colon cancer	4.03e-06	4.61e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—PIK3CA—colon cancer	4.02e-06	4.6e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—KRAS—colon cancer	4.02e-06	4.59e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—TP53—colon cancer	3.99e-06	4.56e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—PIK3CA—colon cancer	3.98e-06	4.55e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—PIK3CA—colon cancer	3.97e-06	4.54e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—PTGS2—colon cancer	3.96e-06	4.53e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Metabolism—AKT1—colon cancer	3.93e-06	4.49e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—TP53—colon cancer	3.92e-06	4.48e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—TP53—colon cancer	3.91e-06	4.47e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—TP53—colon cancer	3.9e-06	4.46e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—TP53—colon cancer	3.89e-06	4.45e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—EP300—colon cancer	3.89e-06	4.44e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—PPARG—colon cancer	3.88e-06	4.44e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—EP300—colon cancer	3.85e-06	4.4e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—TP53—colon cancer	3.85e-06	4.4e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—TP53—colon cancer	3.84e-06	4.39e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—AKT1—colon cancer	3.83e-06	4.38e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—AKT1—colon cancer	3.81e-06	4.36e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—HRAS—colon cancer	3.81e-06	4.36e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—HRAS—colon cancer	3.75e-06	4.29e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—HRAS—colon cancer	3.74e-06	4.28e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—HRAS—colon cancer	3.73e-06	4.27e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—HRAS—colon cancer	3.72e-06	4.25e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—PIK3CA—colon cancer	3.69e-06	4.22e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—HRAS—colon cancer	3.68e-06	4.21e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—HRAS—colon cancer	3.67e-06	4.2e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—AKT1—colon cancer	3.65e-06	4.17e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Metabolism—AKT1—colon cancer	3.6e-06	4.12e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—TP53—colon cancer	3.57e-06	4.08e-05	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—PIK3CA—colon cancer	3.5e-06	4e-05	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—PIK3CA—colon cancer	3.48e-06	3.98e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—HRAS—colon cancer	3.41e-06	3.9e-05	CbGpPWpGaD
Amitriptyline—CYP2B6—Metabolism—AKT1—colon cancer	3.38e-06	3.86e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—AKT1—colon cancer	3.37e-06	3.85e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—AKT1—colon cancer	3.31e-06	3.79e-05	CbGpPWpGaD
Amitriptyline—CYP2E1—Metabolism—AKT1—colon cancer	3.31e-06	3.78e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—AKT1—colon cancer	3.31e-06	3.78e-05	CbGpPWpGaD
Amitriptyline—CYP3A5—Metabolism—AKT1—colon cancer	3.3e-06	3.78e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—AKT1—colon cancer	3.29e-06	3.77e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—EP300—colon cancer	3.29e-06	3.76e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—AKT1—colon cancer	3.28e-06	3.75e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—AKT1—colon cancer	3.25e-06	3.72e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—AKT1—colon cancer	3.24e-06	3.71e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—PIK3CA—colon cancer	3.13e-06	3.57e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—PTGS2—colon cancer	3.06e-06	3.49e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—PIK3CA—colon cancer	3.05e-06	3.49e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—AKT1—colon cancer	3.01e-06	3.45e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—PIK3CA—colon cancer	2.88e-06	3.29e-05	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—AKT1—colon cancer	2.86e-06	3.27e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—PIK3CA—colon cancer	2.85e-06	3.26e-05	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—AKT1—colon cancer	2.84e-06	3.25e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—AKT1—colon cancer	2.55e-06	2.92e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—EP300—colon cancer	2.54e-06	2.9e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—AKT1—colon cancer	2.49e-06	2.85e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—PIK3CA—colon cancer	2.44e-06	2.78e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—AKT1—colon cancer	2.35e-06	2.68e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—AKT1—colon cancer	2.33e-06	2.66e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—AKT1—colon cancer	1.99e-06	2.27e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—PIK3CA—colon cancer	1.88e-06	2.15e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—AKT1—colon cancer	1.54e-06	1.76e-05	CbGpPWpGaD
